THERAVEX Tissue Care Spray Plus for Healing of Skin Wounds and Ulcers

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot observational evaluation examines the safety and potential healing benefits of THERAVEX Tissue Care Spray Plus as an adjunctive topical therapy for cutaneous wounds, including burns, traumatic wounds, pressure ulcers, diabetic ulcers, and chronic lesions. Twenty-six adult patients received THERAVEX spray in addition to standard wound care, with outcomes focused on wound healing progression, epithelialization, tissue hydration, inflammatory signs, tolerance, and overall clinical progression. The study reports favorable tissue responses, progressive epithelial regeneration, reduced inflammation, and no treatment-related adverse events. The investigation discusses wound healing biology and how restoring the extracellular ionic microenvironment with this mineral-based formulation might support endogenous regenerative processes. The findings are preliminary and intended to inform future, more rigorous studies.

Why it matters

Who can join: the full rules

Inclusion Criteria

Adult patients aged 18 years or older. Patients presenting with cutaneous wounds: burns, traumatic wounds, pressure ulcers, diabetic ulcers, or chronic cutaneous lesions.

Patients considered clinically suitable for topical treatment with THERAVEX Tissue Care Spray Plus.

Exclusion Criteria Known allergy or hypersensitivity to any component of THERAVEX Tissue Care Spray Plus.

Presence of severe uncontrolled systemic infection requiring immediate surgical intervention.

Participation in another interventional clinical study that could interfere with wound healing assessment.

Where it's running

• Biointelligent Technology Syst
  Barcelona, Spain Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Sorbact dressings in hard-to-heal wounds

  This study tests whether Sorbact dressings can bind bacteria and fungi from hard-to-heal wounds in adults.

  Recruiting ABIGO Medical AB · Mölndal · NCT05089890

• Using a new micro water jet technology for wound healing

  This study is testing a new water jet device to see if it helps heal different types of wounds better than the usual sharp tools.

  Recruiting Medaxis, LLC · Bradenton, Florida · NCT04920253

• Registry of Chronic Wounds and Ulcers

  This study collects information from patients with chronic wounds and ulcers to see how well different treatments are working and to improve the quality of wound care.

  Recruiting U.S. Wound Registry · The Woodlands, Texas · NCT02280733

• Early detection of sepsis-related blood clotting problems in severe burn patients

  This study tests how well the JAAM-2 score can detect sepsis-induced coagulopathy early in adults with severe burns who develop sepsis in the ICU.

  Recruiting Center for Traumatology and Major Burns, Ben Arous · Tunis · NCT07914205

• BIOxHEAL plus standard care for nonhealing diabetic foot ulcers

  A multicenter study tests whether applying BIOxHEAL, a placental-derived biologic, to stubborn diabetic foot ulcers helps more people heal when added to standard wound care.

  Recruiting Phase 3 Applied Biologics, LLC · Boardman, Ohio · NCT07852338

• Calcaneal Bone Marrow Cells in Foot/Ankle Surgery Patients

  This observational study tests whether routine preoperative blood tests relate to the quality and behavior of mesenchymal stem cells from calcaneal bone marrow in adults undergoing foot or ankle surgery.

  Recruiting Universidade Sao Francisco · Bragança Paulista, São Paulo · NCT07802106

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.